24-hour Movement Behaviors Among Type 2 Diabetes Mellitus Patients

NCT04993482 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 248

Last updated 2023-12-08

No results posted yet for this study

Summary

A healthy lifestyle has proved beneficial health effects in managing type 2 diabetes mellitus (T2DM). Important lifestyle behaviors, i.e. sleep, sedentary time (SB), and physical activity (PA) subdivided into light physical activity (LPA) and moderate to vigorous physical activity (MVPA), have shown an impact on T2DM disease-specific characteristics (e.g. glycemic control). However, these behaviors have often been investigated separately. Therefore, a recent shift in research emphasizes the importance of considering these behaviors as part of a 24-hour day.

Since T2DM patients can benefit from an optimal 24-hour composition as part of a healthy lifestyle, it may be interesting to investigate the 24-hour movement composition among these T2DM patients over time. Moreover, exploring associations with different personal determinants, environmental determinants, and cardiometabolic markers will provide meaningful insights in developing recommendations and creating an intervention.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

No intervention

This project contains a longitudinal observational study design. The investigator will collect data out of a group with type 2 diabetes mellitus patients and out of group with control adults on three time points (baseline, follow-up after one year, and follow-up after two years). Therefore, the investigator will only collect observational data and the participants will not be exposed to a certain intervention.

Sponsors & Collaborators

  • University Ghent

    collaborator OTHER
  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Bruno Lapauw, Professor · Ghent University Hospital - endocrinologist

  • Marieke De Craemer, Professor · University Ghent

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-29
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04993482 on ClinicalTrials.gov